HomeInsightsPE

Indoco Remedies Ltd PE Ratio

Indoco Remedies Ltd PE Ratio

stocks purchased

₹ 0.2 Cr

Volume transacted

stocks purchased

5.3 K

stocks traded

Last Updated time: 19 Sep 15:30 PM

Image

Indoco Remedies Ltd

NSE: INDOCO

PE

49

Last updated: 19 Sep 15:30 PM

Key Highlights

  • The P/E Ratio of Indoco Remedies Ltd is 49 as of 19 Sep 15:30 PM.
  • The P/E Ratio of Indoco Remedies Ltd changed from 79.9 on March 2019 to 30.8 on March 2024 . This represents a CAGR of -17.36% over 5 years. .
  • The Latest Trading Price of Indoco Remedies Ltd is ₹ 367.9 as of 19 Sep 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.2. The PE Ratio of Retail industry is 164.1. The PE Ratio of Textiles industry is 35.8. In 2024.

Historical P/E Ratio of Indoco Remedies Ltd

No data available

Company Fundamentals for Indoco Remedies Ltd

No data available

Image

Indoco Remedies Ltd

NSE: INDOCO

PRICE

367.9

-1.75 (-0.47%)

stock direction

Last updated: 19 Sep 15:30

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Indoco Remedies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 2024367.9
18 Sep 2024369.65
17 Sep 2024375.6
16 Sep 2024366.95
13 Sep 2024371.75
12 Sep 2024373
11 Sep 2024378.25
10 Sep 2024377.85
09 Sep 2024372.55
06 Sep 2024370.75

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Indoco Remedies Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Indoco Remedies Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Revenue of Indoco Remedies Ltd

No data available

* All values are in crore

Historical EBITDA of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Net Profit of Indoco Remedies Ltd

No data available

* All values are in crore

Historical Dividend Payout of Indoco Remedies Ltd

No data available

* All values are in %

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated as a Public Limited Company in August 23, 1947 is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 166 million Company, employs over 6000 people including more than 300 skilled scientists.
  • The Company has 9 manufacturing facilities, 6 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility.
  • Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Indoco Remedies Ltd News Hub

News

Indoco Remedies AGM scheduled

Indoco Remedies announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

31 Aug 202416:28

News

Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

The generic equivalent of Lucemyra Tablets will market to USWM, LLC. 'Indoco has been gran...

Read more

21 Aug 202413:12

News

Indoco Remedies receives USFDA approval for Lofexidine Tablets 0.18 mg

Indoco Remedies announced the receipt of final approval from the USFDA for Abbreviated New...

Read more

21 Aug 202419:58

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 23 July 20...

Read more

11 Jul 202409:31

News

Indoco Remedies receives USFDA approval for Canagliflozin and Metformin Hydrochloride Tablets

Indoco Remedies announced the receipt of tentative approval from the USFDA for Abbreviated...

Read more

07 Jun 202408:40

News

Indoco Remedies gains after receiving USFDA nod for type 2 diabetes drug

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellit...

Read more

06 Jun 202414:47

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Indoco Remedies Ltd

What is the current PE Ratio of Indoco Remedies Ltd?

The Current PE Ratio of Indoco Remedies Ltd is 49.05 as on 19 Sep 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.2 as on 19 Sep 2024.

What was the PE Ratio of Indoco Remedies Ltd last year?

The PE Ratio of Indoco Remedies Ltd was 21.08 last year, now the PE ratio is 49.05, showing a year-on-year growth of 132.7%.

What does the PE Ratio of Indoco Remedies Ltd indicate about its stock?

The PE Ratio of Indoco Remedies Ltd is 49.05. This ratio indicates that investors are willing to pay 49.05 times the earnings per share for each share of Indoco Remedies Ltd.

What is the PE Ratio Growth of Indoco Remedies Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Indoco Remedies Ltd grew by 132.7% whereas, the EPS ratio grew by -91.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*